Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 13th August, 2024, to consider and take on record the standalone and consolidated unaudited financial results of the Company for the 1st quarter ended 30th June, 2024 of the financial year 2024-25. Further, with reference to the above meeting of the Board of Directors, it has already informed vide its letter dated 21st June, 2024 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with immediate effect and until 48 hours after the declaration of the Company’s unaudited financial results for the 1st quarter ended 30th June, 2024 till 15th August, 2024.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1816.10 |
Dr. Reddys Lab | 1340.00 |
Cipla | 1475.70 |
Lupin | 2170.20 |
Zydus Lifesciences | 974.80 |
View more.. |